Implant related infections

1. High-Yield Summary

• Orthopaedic implant-related infections, encompassing periprosthetic joint infection (PJI) and fracture-related infection (FRI), represent devastating complications characterized by bacterial biofilm formation on inert metallic and polymer biomaterials.
• Biofilm architecture confers extreme antibiotic tolerance (up to 1,000-fold minimum biofilm eradication concentration [MBEC] relative to planktonic minimum inhibitory concentration [MIC]), mandating surgical debridement or hardware removal combined with biofilm-active antimicrobial regimens.
• Diagnostic accuracy relies on multidisciplinary scoring criteria (ICM 2018, EBJIS 2021, and Metsemakers FRI consensus) incorporating serum inflammatory markers (CRP, ESR), synovial fluid aspiration (WBC count, differential polymorphonuclear percentage, alpha-defensin), and multiple (minimum 3 to 5) deep intraoperative tissue cultures.
• Surgical management is dictated by timing, implant stability, pathogen virulence, and host soft-tissue envelope: Debridement, Antibiotics, and Implant Retention (DAIR) with modular component exchange is strictly restricted to acute presentations (<3 to 4 weeks from symptom onset or index procedure) with well-fixed components; chronic or loose implants require one-stage or two-stage exchange arthroplasty.
• Postoperative antimicrobial strategy has been transformed by the landmark OVIVA trial, establishing that high-bioavailability oral step-down therapy is non-inferior to prolonged intravenous courses when guided by multidisciplinary infectious disease consultation.

2. Anatomy

Microenvironmental Biomaterial-Tissue Interface

Implantation of foreign biomaterials disrupts local host defense mechanisms and creates a microenvironment vulnerable to bacterial seeding, termed the “race for the surface.” Inert surfaces of titanium alloys, cobalt-chromium, stainless steel, and ultra-high-molecular-weight polyethylene (UHMWPE) are rapidly coated by host plasma proteins, including fibronectin, fibrinogen, vitronectin, and albumin. These host glycoproteins serve as molecular binding ligands for bacterial surface adhesins, notably the Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) expressed by Staphylococci.

Vascularity and Anatomic Dead Space

Surgical dissection, periosteal stripping, and thermal injury from polymethylmethacrylate (PMMA) polymerization devitalize local cortical bone and periprosthetic soft tissues, creating avascular dead space. In the absence of functional microvascular perfusion, systemic antibiotics and host humoral and cellular immune effectors cannot penetrate the infected bed. Surgical eradication requires complete debridement of necrotic bone and avascular fibrous pseudocapsules down to punctate bleeding bone (the “paprika sign”).

Surgical Exposure Planes and Danger Zones

• Hip Arthroplasty Re-exposure: Posterior approach (Kocher-Langenbeck / southern) hazards the sciatic nerve, particularly when scarred into periprosthetic sinus tracts or inflammatory pseudotumors. The direct anterior approach hazards the lateral femoral cutaneous nerve and the ascending branch of the lateral femoral circumflex artery. The anterolateral (Watson-Jones) and direct lateral (Hardinge) approaches hazard the superior gluteal nerve running between gluteus medius and minimus 3 to 5 cm proximal to the greater trochanter tip.
• Knee Arthroplasty Re-exposure: Medial parapatellar or subvastus arthrotomy requires meticulous preservation of the superior and inferior medial genicular arteries. Extensive posterolateral release or lateral hardware extraction puts the common peroneal nerve at risk. Revision exposure in stiff or ankylosed knees may necessitate a rectus snip, V-Y quadriceps turndown, or tibial tubercle osteotomy to prevent patellar tendon avulsion.
• Shoulder Arthroplasty Re-exposure: Deltopectoral approach exploits the internervous plane between the deltoid (axillary nerve) and pectoralis major (medial and lateral pectoral nerves). Retraction of the conjoint tendon hazards the musculocutaneous nerve, which typically enters the coracobrachialis 5 to 8 cm distal to the coracoid tip. The axillary nerve wraps anterior-to-posterior around the humeral neck beneath the subscapularis and along the inferior capsule.
• Diaphyseal Fracture Fixation: Plating and intramedullary nailing corridors must respect neurovascular perforators and superficial cutaneous nerves (e.g., superficial peroneal nerve in lateral ankle/distal fibula exposure; radial nerve crossing the middle-to-distal third posterior humerus).

3. Pathogenesis

Microbiology and Etiologic Agents

The vast majority of implant-related infections are caused by Gram-positive organisms, although polymicrobial and resistant strains increasingly pose clinical challenges:

• Staphylococcus aureus (30% to 40%): Leading pathogen in acute postoperative and acute hematogenous infections. Features aggressive virulence factors, including enterotoxins, alpha-hemolysin, coagulase, and protein A. Methicillin-resistant S. aureus (MRSA) expresses penicillin-binding protein 2a (PBP2a) encoded by mecA.
• Coagulase-Negative Staphylococci (CoNS, 20% to 30%): Predominantly Staphylococcus epidermidis and Staphylococcus lugdunensis. Characteristic agent in delayed, subacute, and low-grade infections. Highly proficient at slime and polysaccharide intercellular adhesin (PIA) synthesis.
• Streptococcus and Enterococcus Species (10% to 15%): Beta-hemolytic Streptococci often produce acute, destructive hematogenous infections. Enterococcus faecalis and Enterococcus faecium form resilient biofilms and exhibit intrinsic resistance to multiple antimicrobial classes (including cephalosporins).
• Cutibacterium acnes (formerly Propionibacterium acnes, 5% to 10%): Anaerobic, aerotolerant Gram-positive bacillus ubiquitous in skin pilosebaceous units of the shoulder girdle and axilla. Characteristic cause of indolent, low-virulence prosthetic shoulder infection, often requiring extended 14-day anaerobic incubation.
• Gram-Negative Bacilli (10% to 15%): Including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Frequently associated with urinary tract instrumentation, abdominal sources, compromised soft-tissue envelopes, or open fracture wounds.
• Culture-Negative Infections (5% to 10%): PJI presenting with clear clinical and histopathologic evidence of infection where standard cultures fail to isolate an organism, frequently caused by prior empirical antimicrobial therapy or fastidious intracellular pathogens.

Biofilm Architecture and Quorum Sensing

Biofilm formation progresses through distinct physiologic stages:

• Initial Adhesion (0 to 24 hours): Free-floating planktonic bacteria adhere to the implant surface through reversible non-specific physicochemical interactions (van der Waals, electrostatic forces, hydrophobic bonds) followed by irreversible MSCRAMM-mediated anchoring to host matrix proteins.
• Proliferation and Accumulation (24 to 72 hours): Bacteria divide and secrete an extracellular polymeric substance (EPS) matrix composed of polysaccharides, extracellular DNA (eDNA), proteins, and amyloid fibrils. This matrix encases the colonies in a protective hydrated slime layer.
• Maturation (3 to 21 days): The biofilm architecture develops complex three-dimensional microcolonies intercalated with fluid-filled nutrient channels. Within mature biofilm, bacteria undergo profound metabolic deceleration into a quiescent, slow-growing or stationary phase (persister cells and small colony variants [SCVs]). Quorum sensing molecules (e.g., autoinducing peptides in Staphylococci) coordinate community behavior.
• Detachment and Seeding: Enzymatic degradation of EPS matrix allows bacterial clusters to detach and disseminate, causing recurrent acute bacteremia, abscess formation, or osteolytic loosening at adjacent bone interfaces.

4. Natural History

The baseline incidence of periprosthetic joint infection following primary total hip and knee arthroplasty ranges between 0.5% and 2.0%, escalating to 3% to 5% following revision procedures. For closed fracture internal fixation, infection rates range from 1% to 3%, whereas open fracture fixation (Gustilo-Anderson Type III) carries infection rates exceeding 15% to 30%.

Host susceptibility is strongly stratified by systemic comorbidities, categorized under the Cierny-Mader and McPherson classification systems. Key independent host risk factors include uncontrolled diabetes mellitus (HbA1c > 7.5% to 8.0%), severe obesity (BMI > 40 kg/m²), active tobacco use, chronic renal insufficiency, inflammatory arthropathies on biologic immunosuppressants, poor nutritional status (serum albumin < 3.5 g/dL, total lymphocyte count < 1,500 cells/mm³), and chronic liver disease.

Untreated implant infection leads inexorably to progressive periprosthetic osteolysis, implant loosening, catastrophic bone stock destruction, chronic draining sinus tracts, intractable pain, sepsis, and limb loss. Even with modern staged revision surgery, the 5-year mortality rate for PJI approaches 20% to 25%, a survivorship curve exceeding that of many common malignancies, highlighting the critical need for aggressive, protocolized management.

5. Clinical Presentation

History

Clinicians must thoroughly interrogate the postoperative timeline and symptom trajectory. In acute postoperative or hematogenous infections, patients present with acute onset of severe pain, joint effusion, wound erythema, and systemic fevers or chills. In delayed, indolent, or low-grade infections (e.g., CoNS, C. acnes), the presentation is subtle: persistent, unexplained dull joint ache, early start-up pain, progressive stiffness, lack of an initial pain-free postoperative interval (“it never felt right”), or persistent wound drainage beyond postoperative day 7 to 10.

In fracture fixation, persistent nonunion, hardware pain on weightbearing, warmth, or recurrent seroma drainage must be presumed infected until proven otherwise.

Physical Exam

• Sinus Tract Inspection: Presence of an active sinus tract or cutaneous fistula communicating directly with the prosthesis or fixation hardware -> Pathognomonic / definitive major confirmatory criterion [Sensitivity 20% to 30%, Specificity 100%].
• Wound Assessment: Evaluation for active purulent drainage, marginal wound dehiscence, progressive erythema extending >2 cm from incision margin, tense fluctuation, and localized hyperthermia.
• Joint Range of Motion and Pain Arc: Provocative active and passive motion testing; acute mechanical pain during gentle axial loading or passive rotation indicates severe intra-articular synovitis or component destabilization.
• Neurovascular and Soft-Tissue Envelope Examination: Comprehensive distal motor, sensory, and vascular assessment; inspection of surrounding skin quality, prior surgical scars, and lymphedematous changes.

6. Imaging and Diagnostic Studies

Serum Inflammatory Biomarkers

Serum C-reactive protein (CRP) and Erythrocyte Sedimentation Rate (ESR) serve as mandatory initial screening tests:

• Serum CRP: Rises rapidly within 6 hours of tissue trauma, peaks at postoperative day 2 to 3, and normalizes within 3 to 6 weeks. A secondary rise or failure to trend downward, or a chronic elevation >10 mg/L (>1.0 mg/dL), has high sensitivity (85% to 95%) and specificity (75% to 85%) for PJI.
• Serum ESR: Peaks at postoperative day 5 to 7 and may remain non-specifically elevated for 3 to 6 months. Chronic threshold >30 mm/hr provides adjunctive diagnostic confirmation (Sensitivity 75% to 85%, Specificity 70% to 80%).
• Serum D-dimer: Demonstrated by the ICM 2018 group as an adjunctive serum marker with a threshold of 850 ng/mL, though systemic inflammatory states, recent trauma, and hematomas can yield false positives.

Diagnostic Synovial Fluid Aspiration

Arthrocentesis must be performed prior to initiating empirical antibiotic therapy (with antibiotics held for a minimum of 2 weeks whenever clinically safe):

• Synovial White Blood Cell (WBC) Count & Differential:
  – Chronic PJI (>6 weeks postoperative): Synovial WBC >3,000 cells/µL (or >2,000 to 3,000 cells/µL) and polymorphonuclear leukocyte percentage (%PMN) >70% to 80%.
  – Acute Postoperative (<6 weeks): Synovial WBC >10,000 cells/µL and %PMN >90%.
• Synovial Alpha-Defensin: Antimicrobial peptide released by activated neutrophils in response to intra-articular pathogens. Unaffected by concurrent antimicrobial administration (Sensitivity >95%, Specificity >95%). Available as laboratory ELISA and point-of-care lateral flow test.
• Synovial Leukocyte Esterase (LE): Reagent strip test detecting neutrophil esterase enzyme; reading ++ (2+) correlates strongly with infection (Sensitivity 80% to 90%, Specificity 90% to 95%). Bloody taps may obscure visual colorimetric interpretation.

Radiographic and Advanced Imaging

• Plain Radiographs (AP, Lateral, Specialized Views): Assess for progressive radiolucent lines (>2 mm at bone-cement or bone-implant interface), rapid periprosthetic osteolysis, focal bone resorption, periosteal reaction (“onion-skinning” in FRI), component migration, subsidence, or nonunion.
• Computed Tomography (CT) with Metal Artifact Reduction (MARS): Accurately delineates periprosthetic bone loss, cortical erosions, occult component loosening, and deep soft-tissue abscesses or fluid collections.
• Nuclear Scintigraphy: Combined 99mTc-sulfur colloid and 111In-labeled white blood cell (WBC/marrow) scintigraphy remains the gold standard nuclear study; discordant uptake (WBC activity exceeding marrow distribution) yields sensitivity and specificity >90%.

Intraoperative Diagnostics

• Histopathology / Frozen Section: Evaluation of at least 2 to 3 periprosthetic tissue specimens; >5 polymorphonuclear neutrophils per high-power field (HPF) in at least 5 separate fields under ×400 magnification indicates active infection.
• Multiple Deep Periprosthetic Tissue Cultures: Minimum of 3 to 5 separate tissue biopsies obtained using separate sterile instruments before administering prophylactic antibiotics. Isolation of phenotypically identical pathogens in >=2 specimens provides definitive microbiological diagnosis. Culturing swabs is strictly prohibited due to poor yield and contamination risks.
• Explant Sonication: Low-frequency ultrasound bath applied to explanted metallic and polymer hardware dislodges sessile biofilm bacteria, achieving superior culture sensitivity (78.5% vs 60.8%), particularly in patients exposed to recent antimicrobials.

7. Classification

Tsukayama / Coventry Classification of Periprosthetic Joint Infection

The Tsukayama-Coventry classification categorizes prosthetic infections by temporal onset and route of inoculation, directly dictating surgical decision-making.

Metsemakers Consensus Definition of Fracture-Related Infection (FRI)

Developed by an international expert consensus group (AO Foundation and EBJIS), this system standardizes diagnostic criteria across orthopaedic trauma.

8. Treatment

Medical / Nonoperative Management

Nonoperative medical management alone is never curative for mature implant-related infections. However, chronic suppressive antibiotic therapy (SAT) is indicated in highly selected scenarios: patients medically unfit for surgical re-intervention, individuals with prohibitive perioperative mortality risks, or patients refusing revision surgery who have stable implants, functional soft-tissue envelopes, and organisms susceptible to well-tolerated oral agents.

Operative Management

The primary goals of surgical intervention are eradication of infection, restoration of stable painless musculoskeletal function, and preservation of soft-tissue and osseous integrity. Four main surgical strategies exist:

• Debridement, Antibiotics, and Implant Retention (DAIR):
  – Technique: Extensive arthrotomy or exposure through prior incision; radical synovectomy, bursectomy, and debridement of all pseudocapsular and necrotic tissue; mechanical pulsatile irrigation (6 to 9 L saline); mandatory removal and exchange of all modular components (polyethylene inserts, modular femoral heads, acetabular liners) to expose and debride the underlying hardware recesses.
  – Prerequisites: Acute timeline (symptoms <3 weeks; index surgery <3 to 4 weeks), well-fixed implants, intact soft-tissue envelope, absence of sinus tract, known pathogen susceptible to oral biofilm-active agents.
• One-Stage Direct Exchange Arthroplasty:
  – Technique: Complete explantation of all components and PMMA cement; radical debridement of all infected soft tissues and unviable bone; complete re-draping and re-instrumentation; immediate implantation of new prostheses using antibiotic-impregnated bone cement (or porous biologic ingrowth components).
  – Prerequisites: Highly selected cases with preoperatively identified, susceptible pathogens (avoiding difficult-to-treat organisms like MRSA, VRE, or multi-drug resistant Gram-negatives), healthy host (Cierny-Mader Type A), uncompromised soft-tissue envelope, and absence of extensive uncontained bone loss.
• Two-Stage Exchange Arthroplasty (North American Gold Standard):
  – Stage 1: Complete hardware removal, comprehensive debridement, extraction of all PMMA cement and foreign bodies, insertion of an antibiotic-loaded acrylic cement (ALAC) spacer. Spacers may be articulating (molded or metal-on-polyethylene prefabricated) or static (block spacer), delivering high local concentrations of heat-stable antibiotics (e.g., 2 to 4 g vancomycin and 2.4 to 4.8 g tobramycin per 40 g batch of PMMA).
  – Interim Phase: Targeted systemic antimicrobial therapy for 6 to 12 weeks guided by infectious disease consultation. Serial monitoring of clinical wound status and normalization of CRP/ESR. A holiday off antibiotics (2 to 4 weeks) with repeat aspiration can confirm eradication prior to reimplantation.
  – Stage 2: Spacer removal, re-debridement, frozen section biopsy to verify resolution, and definitive reconstruction using revision implants with augments or cones as required.
• Fracture-Related Infection Protocols:
  – Stable Hardware with Ununited Fracture: Debridement, irrigation, retention of stable fixation hardware, and culture-directed suppressive antibiotic therapy until fracture union is achieved, followed by planned hardware removal.
  – Unstable Hardware or Loose Implants: Immediate hardware removal, radical debridement, and revision stabilization (external fixator, locked plating, or revision intramedullary nailing with local antibiotic delivery).
  – Healed Fracture: Complete hardware removal, canal reaming, and thorough soft-tissue debridement.
• Salvage Procedures: Indicated for recurrent recalcitrant infections, severe bone and soft-tissue loss, or non-functional limbs: resection arthroplasty (Girdlestone for hip), arthrodesis (knee or shoulder fusion), or amputation (above-knee amputation).

Indications & Contraindications

Strict clinical criteria dictate the choice of surgical pathway:

• Indications for DAIR: Symptom duration <3 weeks in acute hematogenous infection, or presentation <4 weeks following primary surgery; securely fixed components; healthy soft-tissue envelope; susceptible organism identified.
• Contraindications to DAIR: Loose or mechanically compromised components; presence of a sinus tract; chronic infection (>4 weeks duration); unidentifiable organism or difficult-to-treat multi-drug resistant pathogens (e.g., fungal, mycobacterial, resistant Gram-negative); compromised soft-tissue envelope unable to achieve primary closure.
• Indications for Two-Stage Exchange: Chronic PJI with mature biofilm; loose components; resistant or virulent pathogens (MRSA, Enterococcus, Pseudomonas, fungal); compromised host immunity (Cierny-Mader B or C); presence of draining sinus tract; failed prior DAIR or one-stage exchange.

9. Outcome

Infection eradication rates vary markedly across surgical modalities and pathogen profiles. DAIR demonstrates successful infection control in 60% to 80% of strictly selected early acute cases, but success falls below 30% to 40% if modular components are not exchanged, if symptoms exceed 3 weeks, or in the presence of MRSA. Two-stage exchange arthroplasty consistently achieves infection eradication rates of 85% to 92% in major registry cohorts, while one-stage exchange achieves comparable success (85% to 90%) in strictly selected, non-resistant, uncompromised patient populations.

Functional outcomes following two-stage exchange, measured by validated patient-reported outcome measures (PROMs) including Knee Society Scores (KSS), Harris Hip Scores (HHS), and WOMAC, are consistently lower than primary arthroplasty benchmarks due to recurrent surgical trauma, muscle deconditioning, joint stiffness, and joint line alterations. Functional restoration is significantly superior with articulating cement spacers compared to static cement blocks.

Antimicrobial management outcomes have been profoundly redefined by the OVIVA trial (Li et al., NEJM 2019). In a multi-center randomized controlled trial of 1,054 patients with complex bone and joint infections, 1-year definitive treatment failure was 13.2% in patients receiving early oral step-down antibiotics versus 14.6% in patients receiving 6 weeks of intravenous antibiotics. Oral step-down therapy eliminated vascular line-related complications (PICC line thrombosis, bacteremia) while substantially reducing hospitalization duration and healthcare costs.

10. Complications

Implant-related infections and their surgical remediation carry substantial morbidity across the intraoperative, early postoperative, and late surveillance phases.

11. Pearls and Pitfalls

Expert Pearls

• Exchange All Modular Components: When performing DAIR, retention of the original polyethylene insert, modular femoral head, or modular sleeve is a leading cause of failure. Biofilm on the unexposed undersurface of polyethylene cannot be sterilized by mechanical scrub alone; full modular exchange is mandatory.
• Tissue Biopsies Over Swabs: Superficial swabs or sinus tract swabs reflect colonizing cutaneous flora rather than the true pathogen in >50% of cases. Always obtain 3 to 5 distinct deep tissue biopsies with separate clean instruments.
• Antimicrobial Synergy with Rifampin: For staphylococcal implant infections treated with DAIR or one-stage exchange, rifampin demonstrates potent biofilm penetration. Never initiate rifampin as monotherapy or while high bacterial burdens remain, as rapid emergence of resistance occurs within 48 to 72 hours; initiate only after post-surgical debridement and clearance of bacteremia in combination with a companion agent (e.g., fluoroquinolone, vancomycin, or cefazolin).
• Dual-Antibiotic Cement Spacers: Use synergistic combinations in ALAC spacers (e.g., vancomycin for Gram-positives plus tobramycin or gentamicin for Gram-negatives). Dual loading alters the porosity of the cement, significantly enhancing the elution characteristics of both antibiotics.

Pitfalls to Avoid

• Starting Empirical Antibiotics Before Joint Aspiration: Administering oral or intravenous antibiotics prior to obtaining diagnostic synovial fluid or tissue cultures precipitously drops diagnostic culture sensitivity from 85% to <45%, creating high-risk culture-negative scenarios.
• Performing DAIR on Chronic or Loose Components: Attempting DAIR on an implant with >4 weeks of symptoms, radiographic loosening, or a chronic sinus tract results in failure rates exceeding 70% to 80% and progressive bone loss.
• Relying on Normal Inflammatory Markers to Exclude Low-Virulence PJI: Organisms such as Cutibacterium acnes or Staphylococcus epidermidis may produce chronic prosthetic loosening with completely normal serum CRP, ESR, and synovial WBC counts. High clinical suspicion, extended culture incubation (14 days), and frozen section histology are essential.

12. Controversy

One-Stage Versus Two-Stage Exchange Arthroplasty

While two-stage exchange has long been considered the gold standard in North America, European centers have demonstrated equivalent infection eradication rates (85% to 90%) with one-stage direct exchange in carefully selected patients. The benefits of one-stage exchange include avoiding a second major operation, decreased overall morbidity, preservation of joint architecture and soft-tissue planes, and substantial healthcare cost savings. Ongoing prospective randomized trials (such as the INFORM trial) continue to evaluate the non-inferiority of one-stage exchange across broader patient subsets.

Oral Step-Down Versus Prolonged Intravenous Antimicrobials

Historically, standard clinical dogma mandated 6 to 12 weeks of continuous outpatient parenteral antibiotic therapy (OPAT) via peripherally inserted central catheters (PICC). Following publication of the OVIVA trial (Li et al., NEJM 2019), high-quality evidence confirms that oral antibiotics with high bioavailability are non-inferior to intravenous regimens. Debate continues regarding the optimal timing of transition (e.g., after 1 to 2 weeks of IV induction) and the application of oral therapy in patients with complex multi-drug resistant Gram-negative organisms or marginal gastrointestinal absorption.

Extended Incubation Times for Indolent Pathogens

Standard microbiological protocols discard fungal and bacterial cultures after 5 to 7 days. However, Cutibacterium acnes is a slow-growing anaerobe whose colonies frequently do not appear until day 9 to 13 of incubation. While extending routine incubation to 14 days increases diagnostic sensitivity for shoulder and spine implants, it simultaneously increases the risk of identifying secondary skin contaminants, necessitating strict diagnostic algorithms requiring multiple positive cultures.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004. doi:10.1056/NEJMra040181 [Level IV: Seminal Conceptual Synthesis & Clinical Review]
• Li HK, Rombach I, Zambellas R et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med. 2019. doi:10.1056/NEJMoa1710926 [Level I: Randomized Controlled Trial]
• Trampuz A, Piper KE, Jacobson MJ et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007. doi:10.1056/NEJMoa061588 [Level II: Prospective Diagnostic Comparative Study]
• Osmon DR, Berbari EF, Berendt AR et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013. doi:10.1093/cid/cis803 [Level IV: Clinical Practice Guideline]
• Metsemakers WJ, Morgenstern M, McNally MA et al. Fracture-related infection: A consensus on definition from an international expert group. Injury. 2018. doi:10.1016/j.injury.2017.08.040 [Level IV: International Consensus & Diagnostic Algorithm]

15. Master Class Pro-Tip

When executing a DAIR or staged revision for periprosthetic joint infection, the definitive battle is won or lost in the modular interface and the avascular dead space. Never settle for superficial irrigation over retained modular components. Always disassemble the modular liner, femoral head, and any adapters to mechanically debride the hidden crevices where bacterial biofilm clusters survive. During component explantation, resist the temptation to leverage aggressively against weakened periprosthetic cortices; instead, use flexible osteotomes, pencil burrs, and a controlled extended trochanteric osteotomy (ETO) if necessary to preserve structural bone stock. Finally, align antimicrobial strategy with multidisciplinary infectious disease specialists from day one, leveraging the OVIVA trial principles to transition safely to high-bioavailability oral regimens once acute surgical debridement and wound stability are secured.

Master Class Surgical Pearl: Implant Related Infections